Russia has named its first approved COVID-19 vaccine ‘Sputnik V’, in reference to the world’s first satellite, launched by the Soviet Union in 1957. Dmitriev said Russia and its foreign partners are already prepared to manufacture over 500 million doses of the vaccine per year in five countries, and the plan is to ramp up production capacity even higher.
The vaccine’s Phase 3 trial, involving thousands of participants, is set to take place in the UAE, Saudi Arabia, and several other countries. The Russian Health Ministry said in a statement that the vaccine is expected to provide immunity from the coronavirus for up to two years.
The World Health Organization and Russian health authorities are discussing possible WHO pre-qualification of the new vaccine, a WHO spokesman said Tuesday, adding that pre-qualification of any vaccine requires rigorous review and assessment.
- Russia’s COVID-19 vaccine pre-ordered by 20 nations for a billion doses
- Russia approves 2nd coronavirus vaccine
- Vietnam to negotiate with Russia to buy 40 million Covid-19 vaccine doses
- Russia to supply 20 million doses of Covid-19 vaccine to Vietnam
- Vietnam receives 1,000 doses of Russia-made Sputnik V vaccine
- President Putin says Russia is ‘first’ to develop coronavirus vaccine
- Russia to discuss Sputnik-V production cooperation with Vietnam
- Covid 19 vaccine update Controversial Russia s Sputnik V and its availability
- Sputnik V vaccine production factory to be built in Vietnam in one year
- Vietnam to buy 30 million doses of COVID-19 vaccine from UK
